Search Page

1

Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Kim A, Shin DM, Choo MS. Kim A, et al. Among authors: Choo MS. Curr Urol Rep. 2016 Jan;17(1):1. doi: 10.1007/s11934-015-0563-1. Curr Urol Rep. 2016. PMID: 26686192 Review.

Cite

Share

2

Reply by Authors.

Ko KJ, Kim KH, Kim SW, Kim SO, Seo JT, Choo MS, Lee JZ, Oh SJ, Kim HG, Min KS, Kim JH, Lee KS. Ko KJ, et al. Among authors: Choo MS. J Urol. 2019 Sep;202(3):572-573. doi: 10.1097/01.JU.0000558556.60504.cd. Epub 2019 Aug 8. J Urol. 2019. PMID: 31166885 No abstract available.

Cite

Share

3

Effect of preoperative urodynamic detrusor overactivity on post-prostatectomy incontinence: a systematic review and meta-analysis.

Kim M, Park M, Shim M, Choi SK, Lee SM, Lee ES, Song C, Choo MS, Ahn H. Kim M, et al. Among authors: Choo MS. Int Urol Nephrol. 2016 Jan;48(1):53-63. doi: 10.1007/s11255-015-1141-7. Epub 2015 Oct 27. Int Urol Nephrol. 2016. PMID: 26507516 Review.

Cite

Share

4

The Therapeutic Effect of Human Embryonic Stem Cell-Derived Multipotent Mesenchymal Stem Cells on Chemical-Induced Cystitis in Rats.

Lee SW, Ryu CM, Shin JH, Choi D, Kim A, Yu HY, Han JY, Lee HY, Lim J, Kim YH, Heo J, Lee S, Ju H, Kim S, Hong KS, Han JY, Song M, Chung HM, Kim JK, Shin DM, Choo MS. Lee SW, et al. Among authors: Choo MS. Int Neurourol J. 2018 Jan;22(Suppl 1):S34-45. doi: 10.5213/inj.1836014.007. Epub 2018 Jan 31. Int Neurourol J. 2018. PMID: 29385783 Free PMC article.

Cite

Share

5

Factors contributing to treatment outcomes of post-prostatectomy incontinence surgery for the selection of the proper surgical procedure for individual patients: A single-center experience.

Kim M, Choi D, Hong JH, Kim CS, Ahn H, Choo MS. Kim M, et al. Among authors: Choo MS. Neurourol Urodyn. 2018 Aug;37(6):1978-1987. doi: 10.1002/nau.23543. Epub 2018 Mar 5. Neurourol Urodyn. 2018. PMID: 29504655

Cite

Share

6

Is It Possible to Prevent Symptom Recurrence After Transurethral Resection for Hunner Lesion?

Kim A, Shin JH, Choo MS. Kim A, et al. Among authors: Choo MS. Int Neurourol J. 2018 Jun;22(2):145-148. doi: 10.5213/inj.1836082.041. Epub 2018 Jun 30. Int Neurourol J. 2018. PMID: 29991237 Free PMC article. No abstract available.

Cite

Share

7

Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.

Kim A, Han JY, Ryu CM, Yu HY, Lee S, Kim Y, Jeong SU, Cho YM, Shin DM, Choo MS. Kim A, et al. Among authors: Choo MS. Histopathology. 2017 Sep;71(3):415-424. doi: 10.1111/his.13235. Epub 2017 Jun 16. Histopathology. 2017. PMID: 28394416

Cite

Share

8

Drug persistence and compliance affect patient-reported outcomes in overactive bladder syndrome.

Kim TH, Choo MS, Kim YJ, Koh H, Lee KS. Kim TH, et al. Among authors: Choo MS. Qual Life Res. 2016 Aug;25(8):2021-9. doi: 10.1007/s11136-015-1216-z. Epub 2015 Dec 24. Qual Life Res. 2016. PMID: 26701707 Clinical Trial.

Cite

Share

9

Health Related Quality of Life in Patients with Side-Effects after Antimuscarinic Treatment for Overactive Bladder.

Kim A, Lee KS, Jung R, Na S, Kim JC, Kim HG, Choo MS. Kim A, et al. Among authors: Choo MS. Low Urin Tract Symptoms. 2017 Sep;9(3):171-175. doi: 10.1111/luts.12132. Epub 2016 Jun 12. Low Urin Tract Symptoms. 2017. PMID: 27291463 Clinical Trial.

Cite

Share

10

Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment.

Kim A, Lee KS, Kim TB, Kim HJ, Yoo ES, Yun JH, Kim DY, Jung SG, Lee JT, Kim JM, Oh CK, Shin JH, Jeon SH, Lee SH, Han CH, Lee DH, Cho HJ, Choo MS. Kim A, et al. Among authors: Choo MS. Investig Clin Urol. 2017 Jan;58(1):42-47. doi: 10.4111/icu.2017.58.1.42. Epub 2017 Jan 5. Investig Clin Urol. 2017. PMID: 28097267 Free PMC article. Clinical Trial.

Cite

Share